Accugenix Transitions
Accugenix has completed another step of its management transition as Roger Nalepa has been promoted to the position of CEO & President. Former CEO and founding board member Doug Smith has moved to Vice President of Research & Development and will return to his passion. He feels confident with Nalepa taking the reins: �Accugenix is looking to expand, and Roger has the leadership experience and demonstrated success for such a transition.�
Says Roger Nalepa:
�Our skill sets complement one another very well; Doug�s entrepreneurship and technical expertise have made him a leader in cutting-edge technology, whereas my management and international leadership experience have prepared me to coordinate our people to deliver our objectives and strategic vision.�
The Newark based DNA sequencing lab has sales throughout the country and around the world. With estimated revenues over $7m and the new management in place, Accugenix will be moving forward with new initiatives to improve DNA sequencing assays, bacterial and fungal identification libraries, cost, and on-time delivery, and continually innovating solutions to customer problems.
Accugenix participates in a number of industry meetings and conferences. They will be available at:
- IBC’s 4th Intl. BMD Summit, Durham, NC Dec. 8-9, 2008
- Rapid Microbiological Methods Conference, Berlin, Germany Dec. 9-10, 2008
- Accugenix Seminar, Seattle, WA Dec. 12, 2008
- PDA 2009 Annual Meeting, Las Vegas, NV April 20-22, 2009